Literature DB >> 8897438

Neurotrophin receptors, tumor progression and tumor maturation.

S Påhlman1, J C Hoehner.   

Abstract

The nerve growth factor receptor TrkA was initially isolated as a transforming oncogene, trk, in which most of the extracellular receptor part is replaced by the coding sequence for a tropomyosin-encoding gene. The impact that the identification of the first neurotrophin receptor has made on the entire field of developmental neurobiology cannot be overstated. Following a brief introduction to the biology of neurotrophins and their receptors, this review will focus on oncogenic Trk in human malignant disorders, discuss putative tumorigenic involvement of Trk family members in the childhood malignancy neuroblastoma, and point out potential neurotrophin-based treatment modalities for this and other neuroendocrine tumors.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8897438     DOI: 10.1016/1357-4310(96)84847-7

Source DB:  PubMed          Journal:  Mol Med Today        ISSN: 1357-4310


  5 in total

1.  TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung.

Authors:  Alberto Ricci; Claudia De Vitis; Alessia Noto; Luigi Fattore; Salvatore Mariotta; Emanuela Cherubini; Giuseppe Roscilli; Giuseppina Liguori; Giosuè Scognamiglio; Gaetano Rocco; Gerardo Botti; Enrico Giarnieri; Maria Rosaria Giovagnoli; Giorgio De Toma; Gennaro Ciliberto; Rita Mancini
Journal:  Cell Cycle       Date:  2013-05-02       Impact factor: 4.534

2.  Expression of the ALK tyrosine kinase gene in neuroblastoma.

Authors:  L Lamant; K Pulford; D Bischof; S W Morris; D Y Mason; G Delsol; B Mariamé
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

3.  Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia.

Authors:  G W Reuther; Q T Lambert; M A Caligiuri; C J Der
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

4.  Neurotrophin receptor tyrosine kinases regulated with near-infrared light.

Authors:  Anna V Leopold; Konstantin G Chernov; Anton A Shemetov; Vladislav V Verkhusha
Journal:  Nat Commun       Date:  2019-03-08       Impact factor: 14.919

5.  Neuroblastoma patient-derived xenograft cells cultured in stem-cell promoting medium retain tumorigenic and metastatic capacities but differentiate in serum.

Authors:  Camilla U Persson; Kristoffer von Stedingk; Daniel Bexell; My Merselius; Noémie Braekeveldt; David Gisselsson; Marie Arsenian-Henriksson; Sven Påhlman; Caroline Wigerup
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.